内窥镜鼻窦手术后不同药物雾化吸入临床疗效评价  

Observation of curative effect of atomizing inhalation in post operation of ESS

作　　者：石尧机[1] 邓端燕[1] 

机构地区：[1]广西壮族自治区北海市人民医院耳鼻咽喉科,536000

出　　处：《淮海医药》2005年第5期364-365,共2页Journal of Huaihai Medicine

摘　　要：目的探讨内窥镜鼻窦手术(ESS)术后雾化吸入对疗效的影响。方法对行ESS手术后坚持随访3个月以上的217例(345侧)慢性鼻窦炎鼻息肉型期患者随机分为3组:术后分别用生理盐水(A组);生理盐水+庆大霉素+α-糜蛋白酶+地塞米松(B组);生理盐水+沐舒坦(C组)雾化吸入,按海口(1997)ESS疗效标准进行评定。结果C组疗效优于A,B组,差异有显著性。结论术后坚持雾化吸入有重要意义;沐舒坦+生理盐水雾化吸入疗效显著。Objective To explore the influence of atomizing inhalation on post operative irrigation of ESS, Methods 217 patients in stage Ⅱ of type Ⅱ were divided into three groups randomly. Group A were only given normal saline. Group B were given normal saline plus Gentamycin ,α-chymortrypcin and DXM. Group C were given normal saline plus Mucosolvan. An evaluation was made in the three groups according to the ESS standard of Haikou in 1997. Results Effects on group C were better than groups A and B after 3-mouth follow-up. There is a great significance. Conclusion It is shown that patients should have atomizing inhalation continually,which is important after the operation.

关 键 词：鼻窦炎 内窥镜鼻窦手术 投药 吸入 

分 类 号：R765.41[医药卫生—耳鼻咽喉科]